Scott M. Stevens

Scott M. Stevens, MD

Languages spoken: English

Academic Information

Departments Primary - Internal Medicine

Divisions: General Medicine

Board Certification

  • American Board of Internal Medicine (Internal Medicine)

Scott M. Stevens, M.D., F.A.C.P., is the Co-Director of the Thrombosis Clinic at Intermountain Medical Center. This service was established in 2004 and is one of the few clinical services in the state of Utah dedicated to the management of patients with Venous Thrombosis. Dr. Stevens and the Thrombosis Clinic team provide evaluation and management of complex thrombosis cases in both the outpatient and inpatient settings, and have maintained a leading edge approach to the diagnosis and management of thrombosis and anticoagulation therapy.

Education History

Undergraduate Westmont College
 BA
Professional Medical Loma Linda University
 MD
Residency LDS Hospital
 Resident
Chief Resident LDS Hospital
 Chief Resident

Selected Publications

Journal Article

  1. Jacobs V, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, Mallender C, Osborn JS, Stevens SM, Weiss JP, Woller SC, Bunch T (2016). Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation. The American journal of cardiology, 118(2), 210-4. (Read full article)
  2. Rizzi SA, Knight S, May HT, Woller SC, Stevens SM, Steinberg BA, Bair TL, Anderson JL, Muhlestein JB, Knowlton KU, Bunch T (2021). Depression as a Driving Force for Low Time in Therapeutic Range and Dementia in Patients With and Without Atrial Fibrillation. The American journal of cardiology, 153, 58-64. (Read full article)
  3. Kearon C, Spencer FA, O'Keeffe D, Parpia S, Schulman S, Baglin T, Stevens SM, Kaatz S, Bauer KA, Douketis JD, Lentz SR, Kessler CM, Moll S, Connors JM, Ginsberg JS, Spadafora L, Julian J (2015). D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. Annals of internal medicine, 162(1), 27-34. (Read full article)
  4. Stevens S (2020). Something old, something new¿. Blood, 135(16), 1307-1308. (Read full article)
  5. Bledsoe JR, Woller SC, Stevens SM, Aston V, Patten R, Allen T, Horne BD, Dong L, Lloyd J, Snow G, Madsen T, Fink P, Elliott C (2021). Cost-effectiveness of managing low-risk pulmonary embolism patients without hospitalization. The low-risk pulmonary embolism prospective management study. The American journal of emergency medicine, 41, 80-83. (Read full article)
  6. Bates SM, Jaeschke R, Stevens SM, Goodacre S, Wells PS, Stevenson MD, Kearon C, Schunemann HJ, Crowther M, Pauker SG, Makdissi R, Guyatt G (2012). Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141(2 Suppl), e351S-e418S. (Read full article)
  7. Woller SC, Stevens SM, Adams DM, Evans RS, Lloyd JF, Snow GL, Bledsoe JR, Gay DZ, Patten RM, Aston VT, Elliott C (2014). Assessment of the safety and efficiency of using an age-adjusted D-dimer threshold to exclude suspected pulmonary embolism. Chest, 146(6), 1444-1451. (Read full article)
  8. Willoughby L, Adams DM, Evans RS, Lloyd JF, Stevens SM, Woller SC, Bledsoe JR, Aston VT, Wilson EL, Elliott C (2018). Preemptive Anticoagulation in Patients With a High Pretest Probability of Pulmonary Embolism: Are Guidelines Followed?. Chest, 153(5), 1153-1159. (Read full article)
  9. Stevens SM, Woller SC, Baumann Kreuziger L, Bounameaux H, Doerschug K, Geersing GJ, Huisman MV, Kearon C, King CS, Knighton AJ, Lake E, Murin S, Vintch JRE, Wells PS, Moores L (2021). Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest, 160(6), 2247-2259. (Read full article)
  10. Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing GJ, Huisman MV, Kearon C, King CS, Knighton AJ, Lake E, Murin S, Vintch JRE, Wells PS, Moores L (2021). Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest, 160(6), e545-e608. (Read full article)
  11. Anderson JL, Horne BD, Stevens SM, Woller SC, Samuelson KM, Mansfield JW, Robinson M, Barton S, Brunisholz K, Mower CP, Huntinghouse JA, Rollo JS, Siler D, Bair TL, Knight S, Muhlestein JB, Carlquist J (2012). A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II). Circulation, 125(16), 1997-2005. (Read full article)
  12. Han SY, Palmeri ST, Broderick SH, Hasselblad V, Rendall D, Stevens S, Tenaglia A, Velazquez E, Whellan D, Wagner G, Heitner J (2013). Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting. Journal of electrocardiology, 46(1), 45-50. (Read full article)
  13. Woller SC, Bertin KC, Stevens SM, Jones JP, Evans RS, Lloyd JF, Samuelson KM, Hickman JM, Hanseen RB, Barton S, Aston VT, Elliott C (2012). A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty. The Journal of arthroplasty, 27(1), 1-9.
  14. Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Anderson JL, Li J, Rodriguez T Jr, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, Whipple B, Porche-Sorbet R, Napoli L, Merritt K, Thompson AM, Hyun G, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Dávila-Román V, Eby C (2019). Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial. JAMA, 322(9), 834-842. (Read full article)
  15. Stevens SM, Woller SC, Graves KK, Aston V, Jones J, Snow G, Elliott C (2013). Withholding anticoagulation following a single negative whole-leg ultrasound in patients at high pretest probability for deep vein thrombosis. Clinical and applied thrombosis/hemostasis, 19(1), 79-85. (Read full article)
  16. Woller SC, Stevens SM, Towner S, Olson J, Christensen P, Hamilton S, Newman L, Mott L, Hu P, Brunisholz KD, Long Y, Lloyd J, Evans RS, Cannon W, Elliott C (2015). Computerized clinical decision support improves warfarin management and decreases recurrent venous thromboembolism. Clinical and applied thrombosis/hemostasis, 21(3), 197-203. (Read full article)
  17. Woller B, Daw A, Aston V, Lloyd J, Snow G, Stevens SM, Woller SC, Jones P, Bledsoe (2021). Natural Language Processing Performance for the Identification of Venous Thromboembolism in an Integrated Healthcare System. Clinical and applied thrombosis/hemostasis, 27, 10760296211013108. (Read full article)
  18. Takada T, van Doorn S, Parpia S, de Wit K, Anderson DR, Stevens SM, Woller SC, Ten Cate-Hoek AJ, Elf JL, Kraaijenhagen RA, Schutgens REG, Wells PS, Kearon C, Moons KGM, Geersing G (2020). Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: An individual participant data meta-analysis. Journal of thrombosis and haemostasis, 18(9), 2245-2252. (Read full article)
  19. Jacobs V, Woller SC, Stevens S, May HT, Bair TL, Anderson JL, Crandall BG, Day JD, Johanning K, Long Y, Mallender C, Olson JL, Osborn JS, Weiss JP, Bunch T (2014). Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia. Heart rhythm, 11(12), 2206-13. (Read full article)
  20. Kay AB, Morris DS, Woller SC, Stevens SM, Bledsoe JR, Lloyd JF, Collingridge DS, Majercik (2021). Trauma patients at risk for venous thromboembolism who undergo routine duplex ultrasound screening experience fewer pulmonary emboli: A prospective randomized trial. The journal of trauma and acute care surgery, 90(5), 787-796. (Read full article)
  21. Woller SC, Stevens SM, Kaplan D, Wang TF, Branch DW, Groat D, Wilson EL, Armbruster B, Aston VT, Lloyd JF, Rondina MT, Elliott C (2021). Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. Blood advances, 6(6), 1661-1670. (Read full article)
  22. Woller SC, Stevens SM, Johnson SA, Bledsoe JR, Galovic B, Lloyd JF, Wilson EL, Armbruster B, Evans R (2019). Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis (ARM-DVT): Methods of a prospective single-arm management study. Research and practice in thrombosis and haemostasis, 3(3), 340-348. (Read full article)
  23. Fazili M, Stevens SM, Woller S (2019). Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance. Research and practice in thrombosis and haemostasis, 4(1), 9-12. (Read full article)
  24. Kelly C, Bledsoe JR, Woller SC, Stevens SM, Jacobs JR, Butler AM, Quinn (2019). Diagnostic yield of pulmonary embolism testing in patients presenting to the emergency department with syncope. Research and practice in thrombosis and haemostasis, 4(2), 263-268. (Read full article)
  25. Snyder L, Stevens SM, Fazili M, Wilson EL, Lloyd JF, Horne BD, Bledsoe J, Woller S (2020). Predicting postdischarge hospital-associated venous thromboembolism among medical patients using a validated mortality risk score derived from common biomarkers. Research and practice in thrombosis and haemostasis, 4(5), 872-878. (Read full article)
  26. Woller SC, Stevens SM, Fazili M, Lloyd JF, Wilson EL, Snow GL, Bledsoe JR, Horne B (2021). Post-discharge thrombosis and bleeding in medical patients: A novel risk score derived from ubiquitous biomarkers. Research and practice in thrombosis and haemostasis, 5(5), e12560. (Read full article)
  27. Bledsoe JR, Kelly C, Stevens SM, Woller SC, Haug P, Lloyd JF, Allen TL, Butler AM, Jacobs JR, Elliott C (2021). Electronic pulmonary embolism clinical decision support and effect on yield of computerized tomographic pulmonary angiography: ePE-A pragmatic prospective cohort study. Journal of the American College of Emergency Physicians open, 2(4), e12488. (Read full article)
  28. Stevens S (2022). From 3¿months to forever - oral contraceptives, venous thrombosis and duration of anticoagulation. A challenging decision. British journal of haematology, 199, 9-10. (Read full article)
  29. Woller SC, Stevens SM, Bledsoe JR, Fazili M, Lloyd JF, Snow GL, Horne B (2022). Biomarker derived risk scores predict venous thromboembolism and major bleeding among patients with COVID-19. Research and practice in thrombosis and haemostasis, 6(5), e12765. (Read full article)
  30. Starmer AJ, Spector ND, O'Toole JK, Bismilla Z, Calaman S, Campos ML, Coffey M, Destino LA, Everhart JL, Goldstein J, Graham DA, Hepps JH, Howell EE, Kuzma N, Maynard G, Melvin P, Patel SJ, Popa A, Rosenbluth G, Schnipper JL, Sectish TC, Srivastava R, West DC, Yu CE, Landrigan CP, I-PASS SHM Mentored Implementation Study Group (2022). Implementation of the I-PASS handoff program in diverse clinical environments: A multicenter prospective effectiveness implementation study. Journal of hospital medicine, (Read full article)
  31. Tesfazghi MT, Bass AR, Al-Hammadi N, Woller SC, Stevens SM, Eby CS, Scott MG, Snyder L, Wildes TS, Gage B (2022). Predicting Postoperative Troponin in Patients Undergoing Elective Hip or Knee Arthroplasty: A Comparison of Five Cardiac Risk Prediction Tools. Cardiology research and practice, 2022, 8244047. (Read full article)
  32. Woller IA, Woller SC, Stevens SM, Lloyd JF, Conner KE, Gordon BH, Snow GL, Jones P, Bledsoe J (2022). Synoptic reporting accuracy for computed tomography pulmonary arteriography among patients suspected of pulmonary embolism. Journal of the American College of Emergency Physicians open, 3(5), e12801. (Read full article)
  33. Woller SC, Stevens SM, Kaplan D, Wang TF, Branch DW, Groat D, Wilson EL, Armbruster B, Aston VT, Lloyd JF, Rondina MT, Elliott C (2022). Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. Blood advances, 6(6), 1661-1670. (Read full article)
  34. Bunch TJ, May H, Cutler M, Woller SC, Jacobs V, Stevens SM, Carlquist J, Knowlton KU, Muhlestein JB, Steinberg BA, Anderson J (2022). Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non-valvular atrial fibrillation (cognitive decline and dementia in patients with non-valvular atrial fibrillation [CAF] trial). Journal of arrhythmia, 38(6), 997-1008. (Read full article)
  35. Sanchez-Garcia J, Lopez-Verdugo F, LeCorchick S, Tran A, Gilroy RK, Fujita S, Zendejas I, Gagnon A, Dow S, Krong J, Rodriguez-Davalos MI, Stevens SM, Woller SC, Alonso (2023). Performance of a Prospective Anticoagulation Stratification Algorithm After Liver Transplantation. Transplantation direct, 9(3), e1453. (Read full article)
  36. Hyder SN, Han HB, Ash S, Horne BD, Stevens SM, Woller SC, Barnes G (2023). Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers. Thrombosis research, 227, 45-50. (Read full article)
  37. Parks AL, Stevens S (2023). In intermediate- or high-risk PE, catheter-directed thrombolysis is linked to reduced mortality vs. systemic thrombolysis or anticoagulation. Annals of internal medicine, (Read full article)
  38. Lee Cervi A, Applegate D, Stevens SM, Woller SC, Baumann Kreuziger LM, Punchhalapalli K, Wang TF, Lecumberri R, Greco K, Bai Y, Bolger S, Fontyn S, Schulman S, Foster G, Douketis J (2023). Antithrombotic Management of Patients with Deep Vein Thrombosis and Venous Stents: An International Registry. Journal of thrombosis and haemostasis, (Read full article)
  39. Parks AL, Fazili M, Aston V, Porter TF, Branch DW, Woller SC, Snow GL, Stevens S (2023). Excluding pregnancy-associated deep vein thrombosis with whole-leg ultrasound. Research and practice in thrombosis and haemostasis, 7(7), 102202. (Read full article)
  40. Parks AL, Stevens S (2023). NSAIDs and hormonal contraceptives are linked to VTE in women with no previous thrombotic disease. Annals of internal medicine, 176(12), JC143. (Read full article)
  41. Parks AL, Stevens SM, Woller S (2024). Anticoagulant therapy in renal insufficiency theme: Anticoagulation in complex situations. Thrombosis research, 241, 109097. (Read full article)
  42. Woller SC, Stevens SM, Bledsoe JR, Hellewell J, Kraft A, Butler AM, Fazili M, Lloyd JF, Christensen PS, Peltan ID, Barnes GD, Horne B (2024). Methods of a cluster-randomized, type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk medical patients being discharged to prevent hospital-associated venous thromboembolism. Research and practice in thrombosis and haemostasis, 8(6), 102549. (Read full article)
  43. Kay AB, Morris DS, Woller SC, Stevens SM, Bledsoe JR, Collingridge DS, Jacobs JR, Majercik (2022). The Risk Assessment Profile is suboptimal for guiding duplex ultrasound surveillance in trauma patients. Surgery in practice and science, 11, 100127. (Read full article)
  44. Woller SC, Stevens SM, Wylie JD, Layne B, Dong L, Lloyd JF, Momberger N (2025). Standardized Thromboembolism Prophylaxis in Orthopedic Patients to Prevent Venous ThromboEmbolism Study: A Novel Prospectively Validated Electronic Risk Stratification Tool for Elective Hip and Knee Joint Replacement Patients. JB & JS open access, 10(4), (Read full article)
  45. Woller SC, Stevens SM, Bledsoe JR, Bride D, Lloyd JF, Butler A, Fazili M, Horne B (2025). Risk of venous thromboembolism associated with short-term exposure to fine particulate matter (PM(2.5)) and ozone air pollution. Research and practice in thrombosis and haemostasis, 9(7), 103226. (Read full article)

Review

  1. Stevens SM, Woller SC, Baumann Kreuziger L, Doerschug K, Geersing GJ, Klok FA, King CS, Murin S, Vintch JRE, Wells PS, Wasan S, Moores L (2024). Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021. Chest, (Read full article)

Editorial

  1. Stevens SM, Fazili M, Woller S (2020). Choosing ultrasound technique for suspected deep vein thrombosis: which is best?. Quantitative imaging in medicine and surgery, 10(6), 1418-1421. (Read full article)

Letter

  1. Schwab-Daugherty EM, Peng MR, Caraccio EE, Stevens SM, Woller S (2020). Timing of parenteral anticoagulation after thrombolysis for the treatment of pulmonary embolism. Thrombosis research, 195, 58-61. (Read full article)